$10.1 Million is the total value of ALTEGRIS ADVISORS, L.L.C.'s 14 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SALIX PHARMACEUTICALS INCnote 1.500% 3/1 | $1,491,000 | – | 1,000,000 | +100.0% | 14.69% | – | |
| New | VECTOR GROUP LTDfrnt 1/1 | $1,178,000 | – | 1,000,000 | +100.0% | 11.61% | – | |
| New | HOME INNS & HOTELS MGMT INCnote 2.000%12/1 | $1,044,000 | – | 1,000,000 | +100.0% | 10.29% | – | |
| New | GT ADVANCED TECHNOLOGIES INCnote 3.000%10/0 | $1,028,000 | – | 750,000 | +100.0% | 10.13% | – | |
| MTCN | New | ARCELORMITTAL SA LUXEMBOURGmand cv nt 16 | $884,000 | – | 34,000 | +100.0% | 8.71% | – |
| New | RADIAN GROUP INCnote 3.000%11/1 | $709,000 | – | 500,000 | +100.0% | 6.99% | – | |
| New | ALERE INCnote 3.000% 5/1 | $562,000 | – | 500,000 | +100.0% | 5.54% | – | |
| New | WEB COM GROUP INCnote 1.000% 8/1 | $561,000 | – | 500,000 | +100.0% | 5.53% | – | |
| New | OMNICARE INCdbcv 3.250%12/1 | $534,000 | – | 500,000 | +100.0% | 5.26% | – | |
| New | NUANCE COMMUNICATIONS INCnote 2.750%11/0 | $532,000 | – | 545,000 | +100.0% | 5.24% | – | |
| New | JEFFERIES GROUP INC NEWdbcv 3.875%11/0 | $529,000 | – | 500,000 | +100.0% | 5.21% | – | |
| New | ALBANY MOLECULAR RESH INCnote 2.250%11/1 | $463,000 | – | 500,000 | +100.0% | 4.56% | – | |
| New | CIENA CORPnote 0.875% 6/1 | $383,000 | – | 375,000 | +100.0% | 3.77% | – | |
| New | TIBCO SOFTWARE INCnote 2.250% 5/0 | $250,000 | – | 250,000 | +100.0% | 2.46% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Altegris Holdings, Inc. #1
- Altegris Holdings II, Inc. #2
- AqGen Liberty Acquisition Inc. #3
- AqGen Liberty Management I, Inc. #4
- AqGen Liberty Holdings, LLC #5
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QQQ US 11/18/16 P113 | 9 | Q3 2016 | 49.0% |
| ALBANY MOLECULAR RESH INC | 7 | Q2 2016 | 9.4% |
| INFINERA CORPORATION | 7 | Q2 2016 | 12.2% |
| VEREIT Inc Convertible 3% Due 8/1/2018 FA1 | 7 | Q3 2015 | 8.8% |
| Allergan Public Limited Company Preferred | 6 | Q3 2016 | 21.7% |
| VEREIT Inc Convertible 3 3/4% Due 12/15/2020 JD15 | 6 | Q3 2015 | 4.6% |
| Salesforce.com Inc Convertible 0 1/4% Due 4/1/2018 AO1 | 5 | Q3 2016 | 18.7% |
| Palo Alto Networks, Inc 144A Due 7/1/2019 At Mat | 5 | Q3 2016 | 11.1% |
| NXP SEMICONDUCTORS N V | 4 | Q3 2016 | 15.7% |
| PRICELINE GRP INC | 4 | Q4 2015 | 9.6% |
View ALTEGRIS ADVISORS, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-04-02 |
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-09 |
| 13F-NT | 2023-08-10 |
| 13F-NT | 2023-05-09 |
| 13F-NT | 2023-02-15 |
| 13F-NT | 2022-10-28 |
| 13F-NT | 2022-07-26 |
| 13F-NT | 2022-05-11 |
| 13F-NT | 2022-02-04 |
View ALTEGRIS ADVISORS, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.